Details checkedClinical trial listing onlyCheckedregistry

Intratympanic dexamethasone versus methylprednisolone sudden-hearing-loss study

Also known as: Dexamethasone or methylprednisolone, Intratympanic steroids for sudden hearing loss

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Not applicable

Status

Unknown

Target Gene

—

Route / Mode

Intratympanic injection

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

China

Population

adult, sudden-hearing-loss

Trial IDs

Mechanism

Randomized multicenter study comparing intratympanic dexamethasone versus methylprednisolone as salvage treatment for sudden hearing loss.

Indications

Sudden Hearing Loss

Notes

Registry-verified academic intratympanic steroid comparison. Current registry status is unknown; this is a generic steroid study, not a specific company program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...

IDs: NCT04129697

Open

Key Events

2020-01-01

Estimated start of intratympanic steroid salvage study

2022-12-31

Estimated completion date listed in registry

Clinical Trials (1)

NCT04129697

Data Checks

institution-led-studyregistry-only-evidencegeneric-drug-studycurrent-status-unknown-in-registrynot-confirmed-current-product

Related Programs

OTO-104 (dexamethasone) by Otonomy

Company: Otonomy · Steroid/Anti-inflammatory · Phase 3

MEEI sudden deafness steroid treatment trial

Sponsor / Institution: Institution-led study · Steroid/Anti-inflammatory · Phase 3

Pamukkale local dexamethasone cochlear implant study

Sponsor / Institution: Institution-led study · Steroid/Anti-inflammatory · Not applicable

Fudan oral prednisone acute tinnitus studies

Sponsor / Institution: Institution-led study · Steroid/Anti-inflammatory · Not applicable

Tuebingen intratympanic dexamethasone catheter SSNHL study

Sponsor / Institution: Institution-led study · Steroid/Anti-inflammatory · Phase 3

Leiden PREDMEN intratympanic methylprednisolone Meniere disease study

Sponsor / Institution: Institution-led study · Steroid/Anti-inflammatory · Phase 3